| Peer-Reviewed

Laboratory Indicators of AKI in the Setting of HELLP Syndrome in Resource-constrained Backgrounds

Received: 23 November 2021    Accepted: 10 December 2021    Published: 24 December 2021
Views:       Downloads:
Abstract

Background: Acute Kidney Injury (AKI) in the setting of HELLPs (HELLP syndrome) brings in a high rate of maternal and perinatal morbidity/mortality. Its diagnosis depends on proper evaluation of relevant laboratory indices; a factor that is very limited in resource-constrained environs. Hence, the current study evaluated some routine laboratory indices of AKI in the setting of HELLPs in resource-constrained backgrounds. Methods: The study was conducted retrospectively at a tertiary hospital in Nigeria among 198 pregnant women diagnosed/managed for HELLPs from 2011-2020. Relevant variables and data were extracted from laboratory and other medical files using a well-designed research pro forma and analyzed using standard guidelines. Results: Among those evaluated, 57.1% (n=115) developed AKI. The AKI cohorts had higher mean plasma creatinine (PCr) and plasma uric acid (PUA) levels but lower 24-hour urine volume (UV) compared to the non-AKI cohorts (p<0.05). PCr and PUA levels increased while 24-hour urine volume (UV) decreased with advancing AKI stages (p<0.05). The PCr, PUA, and 24-hour UV predicted AKI on univariate logistic regression analysis (LRA) (p<0.05). However, on multivariate LRA, PUA level and the 24-hour UV lost their statistical significance while that of PCr level was significantly amplified (OR: 9.440; 95%CI: 6.733-11.202). At a cut-off value of 106.7 µmol/L, PCr level maintained a robust predictive potential (AUC: 0.938; 95%CI: 0.859-1.000; p<0.001) for AKI. Conclusion: PCr had a robust predictive potential of AKI among the studied population. Hence, timely measurement of PCr level should be considered during the management of HELLPs to reduce the burden of AKI among this at-risk group, especially in resource-constrained settings.

Published in American Journal of Laboratory Medicine (Volume 6, Issue 6)
DOI 10.11648/j.ajlm.20210606.16
Page(s) 114-119
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

HELLP, HELLPs, HELLP Syndrome, AKI

References
[1] Rezai S, Faye J, Hughes A, Cheung ML, Cohen JR, Kaia JA, et al. Hemolysis, Elevated Liver Enzymes, and Low Platelets, Severe Fetal Growth Restriction, Postpartum Subarachnoid Hemorrhage, and Craniotomy: A Rare Case Report and Systematic Review. Case Rep Obstet Gynecol. 2017; 2017: 8481290. DOI: 10.1155/2017/8481290.
[2] Lam MTC, Dierking E. Intensive Care Unit issues in eclampsia and HELLP syndrome. Int J Crit Illn Inj Sci. 2017; 7 (3): 136-141. DOI: 10.4103/IJCIIS.IJCIIS_33_17.
[3] Kınay T, Küçük C, Kayıkçıoğlu F, Karakaya J. Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks' Gestation. Balkan Med J. 2015; 32 (4): 359-63. DOI: 10.5152/balkanmedj.2015.15777.
[4] Abildgaard U, Heimdal K. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol. 2013; 166: 117–23.
[5] Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Preeclampsia: a renal perspective. Kidney Int. 2005; 67: 2101–13. DOI: 10.1111/j.1523-1755.2005.00316.x.
[6] Vigil-De Gracia P, Rojas-Suarez J, Ramos E, Reyes O, Collantes J, Quintero A, et al. Incidence of eclampsia with HELLP syndrome and associated mortality in Latin America. Int. J. Gynaecol. Obstet. 2015; 129: 219–22. DOI: 10.1016/j.ijgo.2014.11.024.
[7] Kongwattanakul K, Saksiriwuttho P, Chaiyarach S, Thepsuthammarat K. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome. Int J Womens Health. 2018; 10: 371-377.
[8] Kota LN, Garikapati K, Kodey PD, Gayathri KB. Study on HELLP syndrome--maternal and perinatal outcome. Int J Repro Contracept Obstet Gynecol. 2017; 6 (2): 714-20.
[9] Madge H, Seth S. Maternal and perinatal outcome in patients of preeclampsia with and without HELLP syndrome. Int J Reprod Contracept Obstet Gynecol. 2019; 8 (5): 2065-71.
[10] Gedik E, Yucel N, Sahin T, Koca E, Colak YZ, Togal T. Hemolysis, elevated liver enzymes, and low platelet syndrome: outcomes for patients admitted to intensive care at a tertiary referral hospital. Hypertens Pregnancy 2017; 36: 21–29. DOI: 10.1080/10641955.2016.1218505.
[11] Huang C, Chen S. Acute kidney injury during pregnancy and puerperium: a retrospective study in a single center. BMC Nephrol. 2017; 18: 146. DOI: 10.1186/s12882-017-0551-4.
[12] Ye W, Shu H, Yu Y, Li H, Chen L, Liu J, Li XM. Acute kidney injury in patients with HELLP syndrome. Int Urol Nephrol. 2019; 51 (7): 1199-206.
[13] Liu Q, Ling GJ, Zhang SQ, Zhai WQ, Chen YJ. Effect of HELLP syndrome on acute kidney injury in pregnancy and pregnancy outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2020; 20 (1): 1-9.
[14] Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury working group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012; 2 (1): 1-38.
[15] Novotny S, Lee-Plenty N, Wallace K, Kassahun-Yimer W, Jayaram A, Bofil, JA, et al. Acute kidney injury associated with preeclampsia or hemolysis, elevated liver enzymes, and low platelets syndrome. Pregnancy Hypertens. 2020; 19: 94–99. DOI: 10.1016/j.preghy.2019.11.010.
[16] Wang L, Tang D, Zhao H, Lian M. Evaluation of risk and prognosis factors of acute kidney injury in patients with HELLP syndrome during pregnancy. Front Physiol. 2021; 12: 650826. DOI: 10.3389/fphys.2021.650826.
[17] Gul A, Aslan H, Cebeci A, Polat I, Ulusoy S, Ceylan Y. Maternal and fetal outcomes in HELLP syndrome complicated with acute renal failure. Ren Fail. 2004; 26 (5): 557-62. DOI: 10.1081/jdi-200031750.
[18] Sibai BM, Taslimi MM, el-Nazer A, Amon E, Mabie BC, Ryan GM: Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia. Am J Obstet Gynecol 1986, 155 (3): 501–509.
[19] Ghosh AK, Vashisht K, Varma S, Khullar D, Sakhuja V. Acute renal failure in a patient with HELLP syndrome--an unusual complication of eclampsia. Ren Fail. 1994; 16 (2): 295–8.
[20] Abraham KA, Kennelly M, Dorman AM, Walshe JJ. Pathogenesis of acute renal failure associated with the HELLP syndrome: a case report and review of the literature. Eur J Obstet Gynecol Reprod Biol. 2003; 108 (1): 99–102.
Cite This Article
  • APA Style

    Collins Amadi, Bright Amadi. (2021). Laboratory Indicators of AKI in the Setting of HELLP Syndrome in Resource-constrained Backgrounds. American Journal of Laboratory Medicine, 6(6), 114-119. https://doi.org/10.11648/j.ajlm.20210606.16

    Copy | Download

    ACS Style

    Collins Amadi; Bright Amadi. Laboratory Indicators of AKI in the Setting of HELLP Syndrome in Resource-constrained Backgrounds. Am. J. Lab. Med. 2021, 6(6), 114-119. doi: 10.11648/j.ajlm.20210606.16

    Copy | Download

    AMA Style

    Collins Amadi, Bright Amadi. Laboratory Indicators of AKI in the Setting of HELLP Syndrome in Resource-constrained Backgrounds. Am J Lab Med. 2021;6(6):114-119. doi: 10.11648/j.ajlm.20210606.16

    Copy | Download

  • @article{10.11648/j.ajlm.20210606.16,
      author = {Collins Amadi and Bright Amadi},
      title = {Laboratory Indicators of AKI in the Setting of HELLP Syndrome in Resource-constrained Backgrounds},
      journal = {American Journal of Laboratory Medicine},
      volume = {6},
      number = {6},
      pages = {114-119},
      doi = {10.11648/j.ajlm.20210606.16},
      url = {https://doi.org/10.11648/j.ajlm.20210606.16},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajlm.20210606.16},
      abstract = {Background: Acute Kidney Injury (AKI) in the setting of HELLPs (HELLP syndrome) brings in a high rate of maternal and perinatal morbidity/mortality. Its diagnosis depends on proper evaluation of relevant laboratory indices; a factor that is very limited in resource-constrained environs. Hence, the current study evaluated some routine laboratory indices of AKI in the setting of HELLPs in resource-constrained backgrounds. Methods: The study was conducted retrospectively at a tertiary hospital in Nigeria among 198 pregnant women diagnosed/managed for HELLPs from 2011-2020. Relevant variables and data were extracted from laboratory and other medical files using a well-designed research pro forma and analyzed using standard guidelines. Results: Among those evaluated, 57.1% (n=115) developed AKI. The AKI cohorts had higher mean plasma creatinine (PCr) and plasma uric acid (PUA) levels but lower 24-hour urine volume (UV) compared to the non-AKI cohorts (p<0.05). PCr and PUA levels increased while 24-hour urine volume (UV) decreased with advancing AKI stages (p<0.05). The PCr, PUA, and 24-hour UV predicted AKI on univariate logistic regression analysis (LRA) (p<0.05). However, on multivariate LRA, PUA level and the 24-hour UV lost their statistical significance while that of PCr level was significantly amplified (OR: 9.440; 95%CI: 6.733-11.202). At a cut-off value of 106.7 µmol/L, PCr level maintained a robust predictive potential (AUC: 0.938; 95%CI: 0.859-1.000; p<0.001) for AKI. Conclusion: PCr had a robust predictive potential of AKI among the studied population. Hence, timely measurement of PCr level should be considered during the management of HELLPs to reduce the burden of AKI among this at-risk group, especially in resource-constrained settings.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Laboratory Indicators of AKI in the Setting of HELLP Syndrome in Resource-constrained Backgrounds
    AU  - Collins Amadi
    AU  - Bright Amadi
    Y1  - 2021/12/24
    PY  - 2021
    N1  - https://doi.org/10.11648/j.ajlm.20210606.16
    DO  - 10.11648/j.ajlm.20210606.16
    T2  - American Journal of Laboratory Medicine
    JF  - American Journal of Laboratory Medicine
    JO  - American Journal of Laboratory Medicine
    SP  - 114
    EP  - 119
    PB  - Science Publishing Group
    SN  - 2575-386X
    UR  - https://doi.org/10.11648/j.ajlm.20210606.16
    AB  - Background: Acute Kidney Injury (AKI) in the setting of HELLPs (HELLP syndrome) brings in a high rate of maternal and perinatal morbidity/mortality. Its diagnosis depends on proper evaluation of relevant laboratory indices; a factor that is very limited in resource-constrained environs. Hence, the current study evaluated some routine laboratory indices of AKI in the setting of HELLPs in resource-constrained backgrounds. Methods: The study was conducted retrospectively at a tertiary hospital in Nigeria among 198 pregnant women diagnosed/managed for HELLPs from 2011-2020. Relevant variables and data were extracted from laboratory and other medical files using a well-designed research pro forma and analyzed using standard guidelines. Results: Among those evaluated, 57.1% (n=115) developed AKI. The AKI cohorts had higher mean plasma creatinine (PCr) and plasma uric acid (PUA) levels but lower 24-hour urine volume (UV) compared to the non-AKI cohorts (p<0.05). PCr and PUA levels increased while 24-hour urine volume (UV) decreased with advancing AKI stages (p<0.05). The PCr, PUA, and 24-hour UV predicted AKI on univariate logistic regression analysis (LRA) (p<0.05). However, on multivariate LRA, PUA level and the 24-hour UV lost their statistical significance while that of PCr level was significantly amplified (OR: 9.440; 95%CI: 6.733-11.202). At a cut-off value of 106.7 µmol/L, PCr level maintained a robust predictive potential (AUC: 0.938; 95%CI: 0.859-1.000; p<0.001) for AKI. Conclusion: PCr had a robust predictive potential of AKI among the studied population. Hence, timely measurement of PCr level should be considered during the management of HELLPs to reduce the burden of AKI among this at-risk group, especially in resource-constrained settings.
    VL  - 6
    IS  - 6
    ER  - 

    Copy | Download

Author Information
  • Department of Chemical Pathology, Rivers State University, Port Harcourt, Nigeria

  • Department of Chemical Pathology, Rivers State University, Port Harcourt, Nigeria

  • Sections